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Abstract
Background: In a study by Wagner et al., the CDC Symptom Inventory was validated in a
population selected from the inhabitants of a city in the USA, and proofed reliable for the
assessment of the accompanying symptoms of CFS. The Dutch translation of the CDC Symptom
Inventory is compared to the original and the psychometric properties are presented for patients
in a tertiary care setting.
Methods: One hundred thirty-nine consecutive patients who visited the CFS Center Amsterdam
for the first time were asked to complete the CDC Symptom Inventory in the Dutch Language
Version (DLV) together with the usual set of questionnaires. Sixty-one patients had Chronic
Fatigue (CF) and 78 patients fulfilled the criteria for CFS. Forty-three healthy accompanying persons
completed the CDC Symptom Inventory DLV, the Physical Functioning scale of the Medical
Outcome Survey Short Form-36 DLV, and the Fatigue and Concentration scales of the Checklist
Individual Strength (CIS-20).
Results: The healthy controls group contained fewer women and was overall older than the
patient groups. The influence of gender on the CDC Symptom Inventory DLV was significant but
the effect of age was not. The Dutch version had a good internal consistency and convergent
validity. The results were comparable to the original English version, but the sex-related difference
needs further study.
Conclusion:  The Dutch version of the CDC Symptom Inventory is a reliable tool for the
assessment of the secondary criteria for CFS. The results show that it is comparable to the
outcome of studies in English speaking countries.
Background
Chronic Fatigue Syndrome (CFS) is a disabling state that
was defined by a working group in 1994 [1]. The main
components of the definition are fatigue that is not related
to exercise and not relieved by rest, and eight accompany-
ing symptoms, of which four must be present. The CFS is
incapacitating, with a serious reduction in daily activity.
Several self-rating scales for the presence and severity of
fatigue were developed. Of these, the Multidimensional
Fatigue Inventory (MFI-20) [2] and the Checklist Individ-
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ual Strength (CIS-20) [3] were selected by an international
CFS study group [4]. The same group advised the Medical
Outcomes Survey Short-Form-36 (SF-36) as the tool for
the assessment of functional impairment. For the pres-
ence of the accompanying symptoms of CFS, a symptom
checklist developed by the Centers for Disease Control
and Prevention was suggested. The MFI-20 and the CIS-20
were developed in the Dutch language and validated. The
SF-36 was translated and validated [5]. The CDC Symp-
tom Inventory was validated for the English-speaking
countries [6]. The translation in Dutch was considered
necessary for comparison of data in CFS research in the
Netherlands and other countries. The objective of the
present study was to translate the CDC Symptom Inven-
tory and to validate it for the Dutch speaking population.
Methods
The participants in the study were all patients who
attended the CFS Center Amsterdam for the first time for
diagnosis and treatment of chronic fatigue from August
2005 to August 2006 and their healthy accompanying per-
sons. No investigations were added to the standard diag-
nostic protocol for new patients in the Center and the
accompanying persons were asked to complete the ques-
tionnaires only. Accompanying persons who reported
fatigue of one month or more, or were ever identified with
medical or psychiatric conditions exclusionary for CFS
were excluded from the study. All participants gave
informed consent for the use of their data for this study.
The CIS-20 is a 20-item self-report instrument that meas-
ures 4 dimensions of fatigue: fatigue, concentration,
impaired motivation and impaired activity. For clinical
assessment of fatigue we used the fatigue and concentra-
tion subscales. The CDC Symptom Inventory DLV was
used for the assessment of the presence of additional
symptoms and their severity. Symptoms were rated as sug-
gested by Wagner et al. [6]. We calculated the CDC Symp-
tom Inventory DLV Total Score, the CDC Symptom
Inventory DLV Short Form, the CDC Symptom Inventory
DLV Case Definition Score and the CDC Symptom Inven-
tory DLV Other Symptoms score as indicated by the
authors. The severity of physical impairment was meas-
ured with the physical functioning subscale of the SF-36.
All healthy controls completed a list of questions about
health, medical interventions in the past and drug use. A
physical checkup and laboratory data according to the rec-
ommendations of Fukuda et al. [1] were obtained from all
patients.
Translation
The English version of the CDC Symptom Inventory was
translated into Dutch by a native Dutch speaker fluent in
English. The translation was presented to 4 native Dutch
speakers for problems in acceptance and comprehension
of the questionnaire content or the phrasing. The provi-
sional Dutch version was translated back into English by
a native English speaker fluent in Dutch.
Statistical analysis
We evaluated the internal consistency of the CDC Symp-
tom Inventory DLV by performing a reliability analysis
based on the model of averaging the inter-item correla-
tion.
In the male and female groups the convergent validity
between the CDC Symptom Inventory DLV, the CIS-20
and the physical score of the SF-36 was tested by the cal-
culation of Pearson's correlation coefficient. Construct
validity by one-way of variance analysis and Bonferroni
post-hoc group comparisons were used to compare the
CDC Symptom Inventory DLV scores, the CIS-20 scores
and the SF-36 score across the three groups. To determine
whether there were differences between CDC groups, a
series of multivariate analyses of covariance was con-
ducted, with physical impairment, fatigue or concentra-
tion as dependant variables and with gender and age as
covariates.
All statistical analyses were carried out using the Statistical
Package for the Social Sciences (SPSS version 14.0).
Results
Forty-three healthy controls completed the question-
naires. Sixty-one patients fulfilled the Fukuda criteria for
chronic fatigue (CF-group) and 78 patients those for
chronic fatigue syndrome (CFS-group) (Table 1). The dif-
ference between men and women was significant for all
scores (Table 2) (Student's t-test P < 0.001). The differ-
ences were partially caused by the age distributions that
were not the same for men and women in the Control, CF
and CFS groups. The difference of the age distribution
between the 3 groups was significant for men and women
together (Jonckheere-Terpstra Test: P  = 0.013). When
tested separately the age differences between the 3 groups
were neither different for women (Jonckheere-Terpstra
Test: P = 0.287) nor for men (Jonckheere-Terpstra Test: P
= 0.177). Analysis of covariance, controlling for age and
Table 1: Characteristics by subject classification (n = 182).
Classification Number Age (Mean ± SD)
Female Male Female Male
CFS 61 17 39 (13) 44 (12)
CF 47 14 37 (12) 42 (10)
Controls 19 24 47 (16) 48 (12)
CFS: patients with chronic fatigue syndrome, CF: patients with 
chronic fatigue, not meeting the criteria for CFS, and healthy controls 
without fatigue complaints.Population Health Metrics 2006, 4:12 http://www.pophealthmetrics.com/content/4/1/12
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gender, demonstrated significant differences between the
three groups [Λ = .165, F (6,174) = 84.7, p < .000]. The
analysis for men and women was done separately.
Reliability analysis
Reliability analyses showed good internal consistency for
the CDC Symptom Inventory Total score with a Cron-
bach's alpha coefficient of 0.86 for women and 0.91 for
men. Cronbach's alpha coefficients were 0.85 (women)
and 0.91 (men) for the Symptom Inventory Short Form,
0.79 and 0.85 for the Symptom Inventory Case Definition
score, and 0.75 and 0.82 for the Symptom Inventory
Other Symptoms score.
Table 2 shows the descriptive data for the Total, Short
Form, Case Definition and the Other Symptoms scores.
Table 3 shows the corrected item-total correlations (prod-
uct terms) of the symptoms for the Total score, the Short
Form and the Case Definition.
Validity
Convergent validity of the CDC Symptom Inventory
The Pearson's correlation coefficient indicated a good
convergent validity of the CDC Total, Case Definition and
Short Form scores as determined by correlations with the
CIS and the SF-36 in men and women (Table 4). Severity
of fatigue coincided with severity of accompanying symp-
toms and physical impairment.
Table 3: Corrected item to total correlations for the CDC Symptom Inventory DLV Total score, the Symptom Inventory Short Form 
score and the Symptom Inventory Case Definition score.
Symptom Corrected item total correlations
Total Score Short Form Case Definition
Female Male Female Male Female Male
Sore throat .40 .28 .34 .30
Tender nodes .42 .24 .37 .22
Diarrhea .40 .47
Unusual fatigue after exertion .66 .82 .69 .86 .61 .84
Muscle aches .48 .63 .44 .57 .59 .67
Joint pain .38 .50 .43 .52
Feverishness .35 .27
Chills .36 .60
Unrefreshing sleep .69 .83 .75 .87 .61 .82
Sleeping problems .64 .72 .66 .78
Headaches .36 .64 .41 .62
Memory problems .56 .66 .56 .64
Concentration .66 .86 .68 .89 .57 .78
Nausea .49 .42
Stomach pain .45 .47
Sinus problems .27 .40
Shortness of breath .38 .41
Sensitivity to light .40 .60
Depression .41 .56
Table 2: Descriptive data of the CDC Symptom Inventory DLV, 
Medical outcomes Survey Short-Form 36 and Checklist 
Individual Health scores.
CDC Symptom Inventory Scores Mean SD Min Max
Female (n = 127)
Total 83.74 45.15 0 201
Short Form 45.78 25.13 0 96
CDC Case Definition 47.61 24.89 0 104
Other Symptoms 36.07 24.02 0 105
SF-36 Physical 57.13 25.21 0 100
CIS Fatigue 47.60 12.00 8 56
CIS Concentration 25.40 8.65 5 35
Male (n = 55)
Total 48.79 48.21 0 158
Short Form 29.89 29.70 0 82
CDC Case Definition 26.96 25.71 0 85
Other Symptoms 21.79 24.58 0 92
SF-36 Physical 74.73 25.77 5 100
CIS Fatigue 34.94 18.90 8 56
CIS Concentration 18.09 10.59 5 35Population Health Metrics 2006, 4:12 http://www.pophealthmetrics.com/content/4/1/12
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Total, Short Form and Case Definition score of the CDC Symptom Inventory – DLV for healthy controls, Chronic Fatigue  patients who did not fulfill the criteria for CFS (CF) and patients with Chronic Fatigue Syndrome (CFS) Figure 1
Total, Short Form and Case Definition score of the CDC Symptom Inventory – DLV for healthy controls, Chronic Fatigue 
patients who did not fulfill the criteria for CFS (CF) and patients with Chronic Fatigue Syndrome (CFS). Error bars indicate 
Standard Error of the Mean.
Table 4: Pearson's correlation matrix of CDC Symptom Inventory DLV, CIS-20 and SF-36 scores for women and men.
Total score Short Form Case Definition
Questionnaires
Women (n = 127) r P r P r P
CIS-20
Fatigue .64 <.001 .69 <.001 .65 <.001
Concentration .65 <.001 .69 <.001 .67 <.001
SF-36
Physical functioning -.68 <.001 -.64 <.001 -.64 <.001
CDC Symptom Inventory DLV
Total .92 <.001 .93 <.001
Short Form .92 <.001 .90 <.001
Men (n = 55)
CIS-20
Fatigue .81 <.001 .82 <.001 .84 <.001
Concentration .79 <.001 .84 <.001 .79 <.001
SF-36
Physical functioning -.84 <.001 -.80 <.001 -.85 <.001
CDC Symptom Inventory DLV
Total .96 <.001 .96 <.001
Short Form .96 <.001 .95 <.001Population Health Metrics 2006, 4:12 http://www.pophealthmetrics.com/content/4/1/12
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Construct validity
The Bonferroni post-hoc comparisons between healthy
controls, chronic fatigue and chronic fatigue syndrome
patients showed significant mean differences related to
CDC Symptom Inventory scores in men and women (Fig-
ures 1 and 2) (Bonferroni post-hoc test; P < 0.001).
Discussion
This evaluation of the clinical application of the Dutch
translation of the CDC Symptom Inventory shows that it
is a reliable tool for the assessment of CFS.
The patients differed in some respects from the popula-
tion studied by Wagner et al. [6]. We analyzed consecutive
patients who attended a tertiary care setting during one
year and their healthy accompanying relatives and friends.
The majority of CFS patients were female, the accompany-
ing friends were male, and the relatives were most often
parents, which explains the difference in the male –
female ratio and age between the healthy controls and the
patients. The gender difference was analyzed and proved
relevant for the outcome.
The differences of the populations explain the different
results of the analyses in the two studies, but the trend is
comparable. The reliability of the scores, expressed as
Cronbach's α coefficient was almost identical in the two
studies. The relation of the outcome of the CDC Symptom
Inventory (DLV) and the SF-36 Physical Functioning score
was comparable. The CIS-20 Fatigue and Concentration
scores in our analysis were closely related to the CDC
Symptom Inventory DLV scores with correlation coeffi-
cients that were comparable to the MFI General Fatigue
and Mental Fatigue scores in the study of Wagner et al. [6].
SF-36 Physical Functioning, CIS Fatigue and CIS Concentration scores for healthy controls, Chronic Fatigue patients who did  not fulfill the criteria for CFS (CF) and patients with Chronic Fatigue Syndrome (CFS) Figure 2
SF-36 Physical Functioning, CIS Fatigue and CIS Concentration scores for healthy controls, Chronic Fatigue patients who did 
not fulfill the criteria for CFS (CF) and patients with Chronic Fatigue Syndrome (CFS). Error bars indicate Standard Error of 
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We limited the number of tests because of clinical rele-
vance for the patients. More tests would have added little
to the clinical diagnosis of CFS.
Conclusion
The Dutch translation of the CDC Symptom Inventory
proved to be a reliable tool in the clinical setting of a ter-
tiary care center. The translated version is reliable and the
results are comparable to the study of a different popula-
tion in an English-speaking country. The different
response of men and women to the tests warrants further
study.
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